Urine Menthol As a Biomarker of Mentholated Cigarette Smoking

Overview

Journal Cancer Epidemiol Biomarkers Prev

Specialties Biochemistry
Oncology
Public Health

Date 2010 Oct 22

PMID 20962297

Citations 31

Authors

Neal L Benowitz

Katherine M Dains

Delia Dempsey

Christopher Havel

Margaret Wilson

Peyton Jacob 3rd

Affiliations

Soon will be listed here.

Abstract

Objectives: Menthol cigarettes are smoked by 27% of U.S. smokers, and there are concerns that menthol might enhance toxicity of cigarette smoking by increasing systemic absorption of smoke toxins. We measured urine menthol concentrations in relation to biomarkers of exposure to nicotine and tobacco carcinogens.

Methods: Concentrations of menthol glucuronide (using a novel analytical method), nicotine plus metabolites (nicotine equivalents, NE), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), and polycyclic aromatic hydrocarbon (PAH) metabolites were measured in the urine of 60 menthol and 67 regular cigarette smokers.

Results: Urine menthol was measurable in 82% of menthol and 54% in regular cigarette smokers. Among menthol smokers, urine menthol was highly correlated with NE, NNAL, and PAHs. In a multiple regression model NE but not menthol was significantly associated with NNAL and PAHs.

Conclusions: Urine menthol concentration is a novel biomarker of exposure in menthol cigarette smokers, and is highly correlated with exposure to nicotine and carcinogens. Menthol is not independently associated with carcinogen exposure when nicotine intake is considered.

Citing Articles

An epidemiological introduction to human metabolomic investigations.

Joshi A, Rahnavard A, Kachroo P, Mendez K, Lawrence W, Julian-Serrano S Trends Endocrinol Metab. 2023; 34(9):505-525.

PMID: 37468430 PMC: 10527234. DOI: 10.1016/j.tem.2023.06.006.

A Method to Amend Cigarettes With Menthol for Use in Research.

Jackson K, Schroeder M, Ai J, Taylor K, Oniyide O, Viray L Nicotine Tob Res. 2023; 25(6):1202-1206.

PMID: 36702747 PMC: 10202838. DOI: 10.1093/ntr/ntad015.

Plasma Menthol Glucuronide as a Biomarker for the Behavioral Effects of Menthol and Nicotine in Humans.

Gueorguieva R, Schwartz E, MacLean R, DeVito E, Eid T, Wu R Front Pharmacol. 2022; 13:844824.

PMID: 35431934 PMC: 9009207. DOI: 10.3389/fphar.2022.844824.

Automated Solid Phase Extraction and Polarity-Switching Tandem Mass Spectrometry Technique for High Throughput Analysis of Urine Biomarkers for 14 Tobacco-related Compounds.

Piyankarage S, McGahee E, Feng J, Blount B, Wang L ACS Omega. 2021; 6(46):30901-30909.

PMID: 34841133 PMC: 8613820. DOI: 10.1021/acsomega.1c02543.

Effects on Smoking Behavior of Switching Menthol Smokers to Non-menthol Cigarettes.

Kotlyar M, Shanley R, Dufresne S, Corcoran G, Okuyemi K, Mills A Nicotine Tob Res. 2021; 23(11):1921-1927.

PMID: 33983396 PMC: 8496474. DOI: 10.1093/ntr/ntab090.

References

Heck J . Smokers of menthol and nonmenthol cigarettes exhibit similar levels of biomarkers of smoke exposure. Cancer Epidemiol Biomarkers Prev. 2009; 18(2):622-9. DOI: 10.1158/1055-9965.EPI-08-0550. View

Jacob 3rd P, Yu L, Wilson M, Benowitz N . Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3',3'-d2 in humans. Biol Mass Spectrom. 1991; 20(5):247-52. DOI: 10.1002/bms.1200200503. View

Sutton C, Robinson R . The marketing of menthol cigarettes in the United States: populations, messages, and channels. Nicotine Tob Res. 2004; 6 Suppl 1:S83-91. DOI: 10.1080/14622203310001649504. View

Hecht S . Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer. 2003; 3(10):733-44. DOI: 10.1038/nrc1190. View

Clark P, Gautam S, Gerson L . Effect of menthol cigarettes on biochemical markers of smoke exposure among black and white smokers. Chest. 1996; 110(5):1194-8. DOI: 10.1378/chest.110.5.1194. View

Muscat J, Chen G, Knipe A, Stellman S, Lazarus P, Richie Jr J . Effects of menthol on tobacco smoke exposure, nicotine dependence, and NNAL glucuronidation. Cancer Epidemiol Biomarkers Prev. 2009; 18(1):35-41. PMC: 2676921. DOI: 10.1158/1055-9965.EPI-08-0744. View

Benowitz N, Jacob 3rd P, Fong I, Gupta S . Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther. 1994; 268(1):296-303. View

Feng S, Kapur S, Sarkar M, Muhammad R, Mendes P, Newland K . Respiratory retention of nicotine and urinary excretion of nicotine and its five major metabolites in adult male smokers. Toxicol Lett. 2007; 173(2):101-6. DOI: 10.1016/j.toxlet.2007.06.016. View

Sidney S, Tekawa I, Friedman G, Sadler M, Tashkin D . Mentholated cigarette use and lung cancer. Arch Intern Med. 1995; 155(7):727-32. View

10.

Dempsey D, Tutka P, Jacob 3rd P, Allen F, Schoedel K, Tyndale R . Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin Pharmacol Ther. 2004; 76(1):64-72. DOI: 10.1016/j.clpt.2004.02.011. View

11.

Okuyemi K, Faseru B, Cox L, Bronars C, Ahluwalia J . Relationship between menthol cigarettes and smoking cessation among African American light smokers. Addiction. 2007; 102(12):1979-86. DOI: 10.1111/j.1360-0443.2007.02010.x. View

12.

Jacob 3rd P, Wilson M, Benowitz N . Determination of phenolic metabolites of polycyclic aromatic hydrocarbons in human urine as their pentafluorobenzyl ether derivatives using liquid chromatography-tandem mass spectrometry. Anal Chem. 2007; 79(2):587-98. DOI: 10.1021/ac060920l. View

13.

Benowitz N, Herrera B, Jacob 3rd P . Mentholated cigarette smoking inhibits nicotine metabolism. J Pharmacol Exp Ther. 2004; 310(3):1208-15. DOI: 10.1124/jpet.104.066902. View

14.

Carmella S, Akerkar S, Richie Jr J, Hecht S . Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. Cancer Epidemiol Biomarkers Prev. 1995; 4(6):635-42. View

15.

Jacob 3rd P, Wilson M, Benowitz N . Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. J Chromatogr. 1981; 222(1):61-70. DOI: 10.1016/s0378-4347(00)81033-6. View

16.

Gelal A, Jacob 3rd P, Yu L, Benowitz N . Disposition kinetics and effects of menthol. Clin Pharmacol Ther. 1999; 66(2):128-35. DOI: 10.1053/cp.1999.v66.100455001. View

17.

Benowitz N, Dains K, Dempsey D, Yu L, Jacob 3rd P . Estimation of nicotine dose after low-level exposure using plasma and urine nicotine metabolites. Cancer Epidemiol Biomarkers Prev. 2010; 19(5):1160-6. PMC: 2867075. DOI: 10.1158/1055-9965.EPI-09-1303. View

18.

Derby K, Cuthrell K, Caberto C, Carmella S, Murphy S, Hecht S . Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer. Int J Cancer. 2009; 125(10):2418-24. PMC: 2779778. DOI: 10.1002/ijc.24585. View

19.

Heatherton T, Kozlowski L, Frecker R, Fagerstrom K . The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991; 86(9):1119-27. DOI: 10.1111/j.1360-0443.1991.tb01879.x. View

20.

Heck J . A review and assessment of menthol employed as a cigarette flavoring ingredient. Food Chem Toxicol. 2010; 48 Suppl 2:S1-38. DOI: 10.1016/j.fct.2009.11.002. View